Upcoming Webinars

Designing production facilities of the future

Presented by Geoffrey Hodge, Chief Technical Officer at Unum Therapeutics and Gary M. Pigeau, Ph.D., Director - Centre for Advanced Therapeutic Cell Technologies at GE Healthcare
30th July 2019


Mapping Future Technology Needs For Real Time Release Testing

Presented by Dr Udayanath Aich, Associate Director at Bristol-Myers Squibb
09th August 2019


Beyond Purely Data-Driven Approaches for Efficient Knowledge Management in Process Development

Presented by Moritz von Stosch, PhD, Senior Manager, Technical R&D, GlaxoSmithKline Vaccines Followed by Klaus Mauch, CEO at Insilico Biotechnology AG and Shilpa Nargund Data Scientist and Business Development Manager at Insilico Biotechnology AG
02nd September 2019


The Journey to Lean Implementation for Efficiency Increase

Presented by Uwe Voelker, Site Head, Sterile Drug Product Manufacturing at Roche
04th September 2019


Case Study and Experience on Sanofi’s Implementation of BPOG’s Leachable Risk Assessment Model

Presented by Ken Wong, Deputy Director at Sanofi Pasteur and Dujuan Lu, Manager/Global Lead of E&L at SGS
10th September 2019


Alternative And Rapid Microbiological Methods: Microbiology Of The 21st Century

Presented by Presented by Dr Benoit Ramond, Head of Microbiology & Sterile Technology, Sanofi and  Dr. David Jones, Director of New Products & Industry Affairs at Rapid Micro Biosystems
12th September 2019


Biopharmaceutical process development – Trends/ Challenges/Opportunities

Presented by Kumar Gaurav, AGM (Regulatory Affairs) at Panacea Biotec Ltd
13th September 2019


Big Data Strategies for Cell Therapy Manufacturing

Presented by Scott R. Burger, MD, Principal, Advanced Cell & Gene Therapy, LLC And Heidi Hagen, Co-founder and Chief Strategy Officer for Vineti Inc
17th September 2019


From Concept to Market – Unique approaches in Biomanufacturing

Presented by Jincai Li, Vice President of WuXi Biologics
18th September 2019


How to Utilize Design of Experiments (DoE) Principles for the Development of High Throughput, Robust Methods for the Assessment of Product Quality

Presented by Jeremy Springall PhD, Scientist II, Analytical Sciences, R&D Biopharmaceutical Development, AstraZeneca
19th September 2019


Characterization of Biotherapeutics

Presented by Diane McCarthy, PhD, Senior Scientific Liaison, Global Biologics, US Pharmacopeia and Dr Kai Scheffler, Product Manager at Thermo Fisher Scientific
24th September 2019


Full-Line Integrated Continuous Process from Upstream to Downstream

Presented by Jackal Tsou, Team Supervisor of Downstream Process Development and Gerben Zijlstra, Global Technology Consultant at Sartorius Stedim Biotech
24th September 2019


Implementation Of An Affordable And Scalable Manufacturing Strategy For Gene Therapy Products

Presented by Bastiaan Leewis, MSAT manager of Industrialization at MeiraGTx and Ankita Desai, Bioprocess Field Application Specialist at Eppendorf
25th September 2019


Cost Considerations for the Application of Continuous Processing

Presented by Narasimha Rao Nedunuri, CEO of CLONZ Biotech and José Castillo, PhD, CTo and co-founder of Univercells
02nd October 2019


Qualification of Raw Materials Used In the Manufacturing of Cellular Therapies

Presented by Fouad Atouf, Ph.D., Director, Biologics and Biotechnology, United States Pharmacopeia and Horst Ruppach, Ph.D. Scientific Director Viral Safety at Charles River
07th October 2019


FDA Perspective on Aseptic Process Simulation for Cell Therapy Product Manufacturing

Presented by Lily Koo, Consumer Safety Officer at Food and Drug Administration
16th October 2019


Upstream Viral Risk Mitigation Strategy for High Titer Biologics Manufacturing

Presented by Aaron Mack, Engineer at Biogen and Dave Kolwyck, Director Materials Science at Biogen and David Gemmel Senior Process Engineer at Merck
17th October 2019


Engineering First Principles: Applications to Pharmaceutical Manufacturing

Presented by Bernard McGarvey, PhD Chemical Engineering
05th November 2019


Just in Time Release of Car-T Cell Therapies

Presented by Irving Ford, Head of CAR T QC Laboratories at Celgene and Lori Daane, Pharma Microbiology Scientific Director at bioMérieux
11th November 2019


Biopharmaceutical Process Model Evolution – Enabling Process Knowledge Continuum from an Advanced Process Control Perspective

Presented by Saly Romero-Torres, PhD, Senior Manager, Advanced Data Analytics, Biogen and David Lovett, Managing Director & John Mack, Engineering Director at Perceptive Engineering
15th November 2019


Identification of unknown extractables and leachables using mass spectrometry: Identification with confidence?

Presented by Petra Booij, Investigator at GlaxoSmithKline
21st November 2019


Monitoring Impurities in Biologics

Presented by Diane McCarthy, PhD, Senior Scientific Liaison, Global Biologics, US Pharmacopeia 
26th November 2019


Qualification of Raw Materials and Cell Substrates for Biomanufacturing

Presented by Maura C. Kibbey, Ph.D., Director, Science & Standards, Global Biologics, U.S. Pharmacopeia and Martin Wisher, PhD, Global Head of Regulatory Affairs at Merck
16th January 2020


Utility of Generating <665> Data: Drug Manufacture’s Perspective: Will USP permit such format?

Presented by Ken Wong, Deputy Director at Sanofi Pasteur and Desmond G. Hunt, Principal Liaison at United States Pharmacopeia
21st January 2020


Identification of Approaches to Simulated Leachable Studies: What are They? When to do Them?

Presented by Jason Creasey, Analytical Chemist at GSK
03rd February 2020


mAb Industry in China : Biosimilars vs Innovative Biologics

Presented by Dr. Joe X Zhou, CEO at Genor Biopharma, Walvax Bio Group and Sarah (Xuyu) Wang, Head of Segment Marketing, Biosimilars and Bioconjugations at Sartorius Stedim Biotech
10th February 2020


High-Resolution Characterization of Structure, Interaction, and Miscibility of Drug Products

Presented by Eric Munson, PhD, Professor and Head at Purdue University
11th February 2020


Rapid Microbial Methods – Reap Benefits And Avoiding Pitfalls

Presented by Dr Andrew Bartko, Research Leader at Battelle Memorial Institute
13th February 2020


Hybrid Models: The Best of Both (Mechanistic & Empirical) Worlds to Accelerate and De-Risk Process Development

Presented by Christian Airiau, PhD, Global Head Data Sciences, Biologics Development at Sanofi
19th February 2020